Stock Groups

CVS expects 70%-80% drop in COVID vaccine administration in 2022 -Breaking

by Mike Robinson

[ad_1]

© Reuters. FILE PHOTO – People pass by CVS Pharmacy in Manhattan, New York City. New York City. November 17, 2021. REUTERS/Andrew Kelly/File Photograph

(Reuters) – CVS Health Corp (NYSE) stated Wednesday that it anticipates administering 70% to 80% fewer COVID-19 vaccinations by 2022 than last year. It also said that the cost of in-store diagnostic testing may drop from 40% to 50%.

According to executives, the company gave more COVID-19 vaccine boosters during the fourth quarter than in the first quarter 2022 as expected.

Disclaimer: Fusion MediaThis website does not provide accurate and current data. CFDs are stocks, indexes or futures. The prices of Forex and CFDs are not supplied by exchanges. They are instead provided by market makers. As such, the prices might not reflect market values and could be incorrect. Fusion Media is not responsible for trading losses that may be incurred as a consequence of the use of this data.

Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information. This includes data including charts and buy/sell signal signals. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.

[ad_2]